Researcher
Jacques De Grève
- Keywords:Medicine
- Disciplines:Cancer biology, Cancer therapy, Cancer prevention
Affiliations
- Medical Genetics (Department)
Member
From1 May 2019 → Today - Laboratory for Medical and Molecular Oncology (Research group)
Member
From1 Jan 2010 → Today - Clinical sciences (Department)
Member
From1 Oct 2023 → Today - Clinical sciences (Department)
Member
From27 May 2019 → 30 Sep 2019 - Clinical sciences (Department)
Member
From8 Apr 2019 → 30 Sep 2023 - Clinical sciences (Department)
Member
From1 Jan 2014 → 20 Oct 2022 - Medical Oncology (Department)
Member
From1 Jul 2012 → 30 Apr 2019 - Medical Oncology (Department)
Member
From1 Jun 2010 → 31 Dec 2011 - Internal Medicine Specializations (Department)
Member
From25 Apr 2005 → 31 Dec 2013 - Medical Imaging and Physical Sciences (Department)
Member
From1 Jan 1999 → 24 Apr 2005
Projects
1 - 6 of 6
- Interdisciplinary Network in Fundamental and Medical Research on Lung and Pancreatic Cancer [NITROGEN]From1 Jul 2021 → TodayFunding: BOF - projects
- SRP-Groeifinanciering: Molecular Portrait of Pancreatic Tumours: Veni, vidi, viciFrom1 Mar 2019 → TodayFunding: BOF - projects
- Interdisciplinary Network for Fundamental and Medical Research on Lung cancerFrom1 Jul 2016 → 30 Jun 2021Funding: University - Project driven research
- FWO-SB-beurs: Innovation through Combination: Identification of a novel combination therapy for improved treatment of EGFRFrom1 Jan 2016 → 31 Dec 2019Funding: FWO fellowships
- BruBreast: Development of diagnostic and therapeutic tools for the optimal management of the individual cancer patient.From1 Jun 2008 → 31 May 2011Funding: Brussels Capital Region
- Critical mutations and signals in breast cancer cells and their stromal environment.From1 Jan 2008 → 31 Dec 2009Funding: FWO research project (including WEAVE projects)
Publications
31 - 40 of 99
- Production of a mono-biotinylated EGFR nanobody in the E. coli periplasm using the pET22b vector 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis(2018)
Authors: Alfiah Noor, Gudrun Walser, Matthijs Wesseling, Philippe Giron, Albert-Menno Laffra, Fatima Haddouchi, Jacques De Grève, Peter Kronenberger
- Therapeutic potential of the vagus nerve in cancer(2018)
Authors: Eva Reijmen, Luca E Vannucci, Marijke De Couck, Jacques De Grève, Yori Gidron
Pages: 38-43 - The prognostic value of 3 commonly measured blood parameters and geriatric assessment to predict overall survival in addition to clinical information in older patients with cancer(2018)
Authors: Abdelbari Baitar, Cindy Kenis, Lore Decoster, Jacques De Grève, Jean-Pierre Lobelle, Johan Flamaing, Koen Milisen, Hans Wildiers
Pages: 3764-3775 - The added value of geriatric screening and assessment for predicting overall survival in older patients with cancer(2018)
Authors: Cindy Kenis, Abdelbari Baitar, Lore Decoster, Jacques De Grève, Jean-Pierre Lobelle, Johan Flamaing, Koen Milisen, Hans Wildiers
Pages: 3753-3763 - Docetaxel/cyclophosphamide chemotherapy in older patients with breast cancer(2018)
Authors: Lore Decoster, Christel Fontaine, Leen Vanacker, Denis Schallier, Jacques De Grève
Pages: 695-697 - Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer(2018)
Authors: Alfiah Noor, Ijeoma Umelo, Peter Kronenberger, Philippe Giron, Elly De Vlieghere, Olivier De Wever, Erik Teugels, Jacques De Grève
Pages: 28731-28744 - Type II RAF inhibitor causes superior ERK pathway suppression compared to type I RAF inhibitor in cells expressing different BRAF mutant types recurrently found in lung cancer(2018)
Authors: Maxim Noeparast, Philippe Giron, Sylvia De Brakeleer, Carolien Eggermont, Ulrike De Ridder, Erik Teugels, Jacques De Grève
Pages: 16110-16123 - Relevance of Geriatric Assessment in Older Patients With Colorectal Cancer(2017)
Authors: Lore Decoster, Leen Vanacker, Cindy Kenis, Hans Prenen, Erik Van Cutsem, Jacques Van Der Auwera, E Van Eetvelde, Katrien Van Puyvelde, Johan Flamaing, Koen Milisen, et al.
Pages: e221-e229 - Breast cancer risk is increased in the years following false-positive breast cancer screening(2017)
Authors: Mathijs Goossens, Isabel De Brabander, Jacques De Grève, Evelien Vaes, Chantal Van Ongeval, Koen Van Herck, Eliane Kellen
Pages: 396-403 - Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1/2 mutated patients with advanced ovarian cancer(2017)
Authors: Saeed Rafii, Charlie Gourley, Rajiv Kumar, Elena Geuna, Joo Ern Ang, Tzyvia Rye, Lee-may Chen, Ronnie Shapira-Frommer, Michael Friedlander, Ursula Matulonis, et al.
Pages: 47154-47160